Evidence map›Paper›PMID 24891521›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2014

Altered hepatic sulfur metabolism in cystathionine β-synthase-deficient homocystinuria: regulatory role of taurine on competing cysteine oxidation pathways.

Hua Jiang, Sally P Stabler, Robert H Allen, Steven H Abman, Kenneth N Maclean

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Transsulfuration Pathway Products and HInternational journal of molecular sciences · 2025
    Review
  3. Review
  4. Article
  5. Spotlight on GOT2 in Cancer Metabolism.OncoTargets and therapy · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Cystathionine β-synthase deficiency: Of mice and men.Molecular genetics and metabolism · 2017
    Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hua JiangDepartment of Pediatrics and.
Sally P StablerDepartment of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA.
Robert H AllenDepartment of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA.
Steven H AbmanDepartment of Pediatrics and.
Kenneth N MacleanDepartment of Pediatrics and ken.maclean@ucdenver.edu.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Hospital · US

Funding

Role of VEGF in Perinatal Pulmonary HypertensionR01HL068702 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ABMAN, STEVEN HERBERT, SHEPHERD, DOUGLAS · 2001 to 2021
$6.7M
NHLBI NIH HHS R01 HL068702
6 · The paper itself

Abstract

Cystathionine β-synthase-deficient homocystinuria (HCU) is a serious life-threatening inborn error of sulfur metabolism with poorly understood pathogenic mechanisms. We investigated the effect of HCU on hepatic cysteine oxidation in a transgenic mouse model of the disease. Cysteine dioxygenase (CDO) protein levels were 90% repressed without any change in mRNA levels. Cysteinesulfinic acid decarboxylase (CSAD) was induced at both the mRNA (8-fold) and protein (15-fold) levels. Cysteine supplementation normalized CDO protein levels without reversing the induction of CSAD. Regulatory changes in CDO and CSAD expression were proportional to homocysteine elevation, indicating a possible threshold effect. Hepatic and blood taurine levels in HCU animals were decreased by 21 and 35%, respectively, and normalized by cysteine supplementation. Expression of the cytoplasmic (GOT1) and mitochondrial (GOT2) isoforms of glutamic-oxaloacetic transaminase were repressed in HCU animals by 86 and 30%, respectively. HCU induced regulatory changes in CSAD, CDO, and GOT1 expression were normalized by taurine supplementation, indicating that cysteine is not the only sulfur compound that regulates hepatic cysteine oxidation. Collectively, our results indicate that HCU induces significant alterations of sulfur metabolism with the potential to contribute to pathogenesis and that cysteine and taurine have the potential to serve as adjunctive treatments in this disease.

Indexed as

AnimalsBlotting, WesternCarboxy-LyasesCystathionine beta-SynthaseCysteineCysteine DioxygenaseDietary SupplementsFemaleHomocystinuriaHumansLiverMaleMethionineMiceMice, Inbred C57BLMice, KnockoutCarboxy-LyasesCystathionine beta-SynthaseCysteineCysteine DioxygenaseMethionineRNA, Messengersulfoalanine decarboxylaseSulfurTaurinecysteinesulfinate decarboxylaseglutamic-oxaloacetic transaminasethiol metabolismtranssulfuration

Identifiers

PMID24891521
PMCPMC5395733
OpenAlexW2084663151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.